PET scan clue may predict tumor treatment success
NCT ID NCT07208487
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a special PET/CT scan done before treatment could predict how well radioactive seed implants would work for malignant tumors. Researchers reviewed data from 41 patients with 69 tumors. They found that a measurement called Metabolic Tumor Volume (MTV) was the best predictor of treatment success—larger tumor volumes were linked to worse outcomes. This information could help doctors choose the right treatment for each patient.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors decide which patients are most likely to benefit from radioactive seed implantation, personalizing cancer treatment.
- What could go wrong
- This is a small, completed retrospective study (41 patients). The findings need to be confirmed in larger, prospective trials before changing practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT TUMORS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jiangxi Cancer Hospital
Nanchang, Jiangxi, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug combo aims to shrink Hard-to-Treat tumors
- Cancer gene study aims to unlock prognosis secrets
- Massive 10-Year health check: what happens when chronic diseases collide?
- X-rays may damage red blood cells: study seeks safe limits
- New scan could sharpen cancer detection
- Smart scans may boost power of radioactive seeds against cancer